Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ThermoGenesis, a developer of automated blood processing systems and disposable products, has appointed Melville Engle as its new CEO.
Subscribe to our email newsletter
Matthew Plavan, who has been serving as the company’s interim CEO since December 2008, has been named the company’s COO. Mr Plavan will also retain his executive vice president and CFO position at the company.
Most recently, Mr Engle served as CEO of Raydiance, a laser technology company. Mr Engle is currently a member of the board of directors of Oxygen Biotherapeutics.
Patrick McEnany, director and chairman of governance and nominating committee at ThermoGenesis, said: “Mel has served as president and CEO of three healthcare companies, as well as having extensive management experience in operations, finance, sales and international market development with both large and small device and pharmaceutical organizations. After conducting an extensive search and interviewing a number of excellent candidates, it was clear to the board that Mel’s wide-ranging healthcare industry experience made him a great fit for ThermoGenesis.”